Coherus Oncology, Inc.
Coherus Oncology, Inc. scores highest on Anchor (56) and lowest on Torque (19). Its PosiPenta is 34.71 out of 100, weaker than most similar companies.
On the Penta Grid this week, Coherus Oncology, Inc. is Grid #678 of 837 in the Healthcare sector in United States, and Grid #3,321 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Coherus Oncology, Inc. | 34.71 | 24 | 50 | 25 | 19 | 56 |
| Upstream Bio, Inc. | 37.96 | 45 | 25 | 6 | 66 | 48 |
| ALX Oncology Holdings Inc. | 43.76 | 39 | 52 | 37 | 44 | 47 |
| Neuronetics, Inc. | 37.65 | 8 | 50 | 60 | 15 | 55 |
| Akebia Therapeutics, Inc. | 25.80 | 9 | 38 | 13 | 15 | 54 |
| Sutro Biopharma, Inc. | 39.16 | 0 | 35 | 31 | 93 | 38 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -0.79 |
| P/B ratio | 2.51 |
EEarnings
| Trailing EPS | ₹-118.39 |
| Forward EPS | ₹-59.67 |
NNitro
| Price | 93.77 |
| 52-week high | 247.77 |
| 52-week low | 92.25 |
| Fall from 52-week high | 62.2% |
TTorque
| Return on equity (ROE) | -178.39% |
| Debt-to-equity | 0.89 |
AAnchor
| Beta (price swings) | 0.99 |
| Market cap | ₹1,448 Cr |
| Insider holding | 19.12% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Coherus Oncology, Inc.'s PosiPenta score?
Coherus Oncology, Inc.'s PosiPenta is 34.71 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Coherus Oncology, Inc. stand on the Penta Grid?
On the Penta Grid this week, Coherus Oncology, Inc. is Grid #678 of 837 in the Healthcare sector in United States, and Grid #3,321 of 4,000 in United States.
Which PosiPenta pillar is strongest for Coherus Oncology, Inc.?
Anchor (stability and dividends), with a score of 56 out of 100: around the middle of similar companies.
Which PosiPenta pillar is weakest for Coherus Oncology, Inc.?
Torque (durability), with a score of 19 out of 100: much weaker than most similar companies.
Has Coherus Oncology, Inc.'s PosiPenta changed since last week?
Yes, it rose 2.05 points, from 32.66 to 34.71.
PositoAI is for research and education only and is not investment advice.